Qatar-bound passenger held with 10-kg ganja hidden in pumpkins at Mangaluru Airport

Bengaluru, May 19: Karnataka State Road Transport Corporation (KSRTC) has begun booking of tickets from May 18. Ticket counters have been opened after implementation of new guidelines for the fourth phase of COVID-19 nationwide lockdown.

People seeking to travel can book the tickets through KSRTC booking counters, authorised franchises booking counters and online, mobile booking, according to a release.

The advanced booking has started for Bengaluru-Shivamogga, Bengaluru-Mysuru, Bengaluru-Mangaluru routes, among others.

Bookings can be made upto 30 days in advance, as per the release.

Amid COVID-19, Bengaluru Metropolitan Transport Corporation has restricted the operation services of the bus between 7 AM to 7 PM, said the release.

Passengers are permitted to travel with social distancing measures while the transport corporation will follow the standard operating procedure issued by the Ministry of Home Affairs.

The MHA had issued updated guidelines after the implementation of the fourth phase of nationwide lockdown on May 17th.

Mangaluru, May 27: Karnataka’s twin coastal districts of Dakshina Kannada and Udupi today reported 11 and 9 fresh covid-19 cases respectively.

In Dakshina Kannada the covid-19 patients include seven women and four men who had recently come from Maharashtra.

One of the patients is a 3-year-old child. Others are girls aged 11 and 17, women aged 36, 37, 45, 59 and men aged 22, 35, 39 and 46.

All of them have been shifted to covid-19 hospital from different institutional quarantine centres. 

In Udupi too all the nine people – six men, a boy, and two women -  had come from Maharashtra a few days ago.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.